Linde AG (LIN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Linde AG (LIN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10093
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. It offers a wide range of compressed, liquefied gases and chemicals. It also offers engineering services to petrochemical and chemical industries. The company offers medical gases and services to healthcare providers and patients in hospitals, and long term care centers. It serves various sectors including energy, steel, chemical, environmental protection, welding, food processing, glass, electronics and others. It has operations in Europe, North America, Asia Pacific, South America and Africa. Linde is headquartered in Munich, Germany.

Linde AG (LIN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Linde AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Linde AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Linde AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Linde AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Linde AG, Medical Devices Deals, 2012 to YTD 2018 9
Linde AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Linde AG, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Linde Completes Acquisition Of Homecare Business From Air Products For US$777 Million 11
Equity Offering 13
Bellerophon Therapeutics Raises USD23.4 Million in Private Placement of Units 13
Linde Announces Private Placement Of Shares For US$1.7 Billion 15
Debt Offering 16
Linde Completes Private Placement Of Notes Due 2020 For US$1.25 Billion 16
Acquisition 17
Linde To Acquire Calea France From Fresenius Kabi 17
Linde Completes Acquisition Of Lincare, Provider Of Respiratory Therapy Services, For US$4.6 Billion 18
Linde AG – Key Competitors 20
Linde AG – Key Employees 21
Linde AG – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 27
Recent Developments 28
Financial Announcements 28
Jul 25, 2018: Linde business performs well in the first half-year – significant increase in group earnings 28
Apr 25, 2018: Linde: January to March 2018: Linde makes a good start to the new year – significant increase in Group earnings 30
Corporate Communications 32
May 03, 2018: New Supervisory Board Elected At Linde AGM – Professor Dr Wolfgang Reitzle Confirmed As Chairman 32
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Linde AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Linde AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Linde AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Linde AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Linde AG, Deals By Therapy Area, 2012 to YTD 2018 8
Linde AG, Medical Devices Deals, 2012 to YTD 2018 9
Linde AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Linde Completes Acquisition Of Homecare Business From Air Products For US$777 Million 11
Bellerophon Therapeutics Raises USD23.4 Million in Private Placement of Units 13
Linde Announces Private Placement Of Shares For US$1.7 Billion 15
Linde Completes Private Placement Of Notes Due 2020 For US$1.25 Billion 16
Linde To Acquire Calea France From Fresenius Kabi 17
Linde Completes Acquisition Of Lincare, Provider Of Respiratory Therapy Services, For US$4.6 Billion 18
Linde AG, Key Competitors 20
Linde AG, Key Employees 21
Linde AG, Subsidiaries 22
Linde AG, Joint Venture 27

List of Figures
Linde AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Linde AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Linde AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Linde AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Linde AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Linde AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Linde AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Linde AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Linde AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Linde AG (LIN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Haitong Securities Co., Ltd.:企業の戦略・SWOT・財務分析
    Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • US Foods, Inc.:企業の戦略・SWOT・財務分析
    US Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary US Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The Scoular Company:戦略・SWOT・企業財務分析
    The Scoular Company - Strategy, SWOT and Corporate Finance Report Summary The Scoular Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Air Water Inc (4088):企業の財務・戦略的SWOT分析
    Air Water Inc (4088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Labeyrie Fine Foods:企業の戦略・SWOT・財務分析
    Labeyrie Fine Foods - Strategy, SWOT and Corporate Finance Report Summary Labeyrie Fine Foods - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vectren Corp (VVC):電力:M&Aディール及び事業提携情報
    Summary Vectren Corp (Vectren) is an energy holding company, which carries out the distribution and transmission of natural gas and electricity. Under its wholly owned subsidiary, Vectren Utility Holdings, Inc., the company operates three utilities; Vectren Energy Delivery of Indiana - North (Vectre …
  • China Digital Culture (Group) Ltd (8175):企業の財務・戦略的SWOT分析
    China Digital Culture (Group) Ltd (8175) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Banco ABC Brasil SA (ABCB4):企業の財務・戦略的SWOT分析
    Banco ABC Brasil SA (ABCB4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Median Technologies SA (ALMDT):企業の財務・戦略的SWOT分析
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed service …
  • StormGeo AS:石油・ガス:M&Aディール及び事業提携情報
    Summary StormGeo AS (StormGeo) is a weather forecast company that offers professional weather services and decision support for weather sensitive operations. The company operates through segments that include shipping, oil and gas, marine operations, renewable, aviation, cross industry and media. It …
  • Zimplats Holdings Ltd:企業の戦略・SWOT・財務分析
    Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Callidus Software Inc (CALD):企業の財務・戦略的SWOT分析
    Summary Callidus Software Inc (Callidus) a subsidiary of SAP SE, operates as a technology company that offers a cloud-based customer relationship management (CRM) solutions. The company’s product portfolio includes contract life cycle management (CLM), configure price quote (CPQ) solutions, clicktoo …
  • Intermountain Healthcare Inc-製薬・医療分野:企業M&A・提携分析
    Summary Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, …
  • Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析
    Summary Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company’s product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs …
  • Morphotek Inc-製薬・医療分野:企業M&A・提携分析
    Summary Morphotek Inc (Morphotek), a subsidiary of Eisai Co Ltd is a clinical-stage biotech company that develops novel classes of biological based products. The company offers a pipeline of monoclonal antibodies, antibody drug conjugates, and bispecific antibodies for the treatment of cancer, infla …
  • Kaneka Corp (4118):企業の財務・戦略的SWOT分析
    Kaneka Corp (4118) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Masraf Al Rayan (Q.S.C.):企業の戦略・SWOT・財務情報
    Masraf Al Rayan (Q.S.C.) - Strategy, SWOT and Corporate Finance Report Summary Masraf Al Rayan (Q.S.C.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Trellis Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Trellis Bioscience Inc (Trellis) is a drug development company that discovers and develops human antibody therapeutics for the treatment of bacterial and viral infectious diseases and cancer indications. The company’s clinical candidate includes TRL1068, which targets and disintegrates bacte …
  • University of Oxford:企業のM&A・事業提携・投資動向
    University of Oxford - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Oxford Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Cadila Healthcare Ltd (CADILAHC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cadila Healthcare Ltd (Zydus Cadila) is an integrated, global healthcare provider. It discovers, develops, manufactures and markets various healthcare products. The company’s product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆